Sunflower Pharmaceuticals Group Co (葵花药业) is a private business specializing in research and development, manufacturing and marketing of Chinese patent medicine. Its headquarters is located in Harbin, capital of Northeast China's Heilongjiang province.
It was listed on the Shenzhen Stock Exchange in 2014. The company's annual income reached 33.64 billion yuan($5.08 billion) in 2016.
It The company has 23 subsidiaries, including 12 medicine manufacturing businesses, one pharmaceutical research institute and a medicinal materials planting base.
It also has six main product categories, which are pediatrics, gynecology, digestive system, respiratory system, rheumatism and orthopedics, as well as cardiovascular system. Its self-developed medicine for liver and stomach are among the most well-known Chinese patent medicine nationwide.
The research institute has set up branches in Beijing and Harbin, focusing on the research and development of natural medicine, chemical medicine and new types of preparations.
The group has established partnership with more than 800 pharmaceutical businesses and 3,000 hospitals.